Heterogeneity in glucose response curves during an oral glucose tolerance test and associated cardiometabolic risk

Endocrine

Volumn 55, Issue 2, 2017, Pages 427-434

  Hulman, Adam ^a,b,c   Simmons, Rebecca K ^a,b,d   Vistisen, Dorte ^e   Tabák, Adam G ^f,g   Dekker, Jacqueline M ^h   Alssema, Marjan ^h,i   Rutters, Femke ^h   Koopman, Anitra D M ^h   Solomon, Thomas P J ^j   Kirwan, John P ^k   Hansen, Torben ^l   Jonsson, Anna ^l   Gjesing, Anette Prior ^l   Eiberg, Hans ^m   Astrup, Arne ^m   Pedersen, Oluf ^l   Sørensen, Thorkild I A ^l,n   Witte, Daniel R ^a,b   Færch, Kristine ^e  

^a AARHUS UNIVERSITY   (Denmark)

^b The Danish Diabetes Academy   (Denmark)

^c UNIVERSITY OF SZEGED   (Hungary)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e STENO DIABETES CENTER   (Denmark)

^f SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

^h VU UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ UNILEVER RESEARCH VLAARDINGEN   (Netherlands)

^j UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^k LERNER RESEARCH INSTITUTE   (United States)

^l Capital Region   (Denmark)

^m UNIVERSITY OF COPENHAGEN   (Denmark)

ⁿ The Capital Region   (Denmark)

more..

Author keywords

Cardiometabolic risk; Glucose response curve; Latent class trajectory analysis; Oral glucose tolerance test

Indexed keywords

GLUCOSE; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DENMARK; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; POPULATION RESEARCH; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING HABIT; UNITED STATES; ANALYSIS; BLOOD; DIABETES MELLITUS, TYPE 2; DIET RESTRICTION; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; MIDDLE AGED;

ADULT; BLOOD GLUCOSE; DENMARK; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; SEX FACTORS; UNITED STATES;

EID: 84989898326     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-016-1126-z     Document Type: Article

References (33)

1. K. Faerch, A. Hulman, T.P. Solomon, Heterogeneity of Pre-diabetes and Type 2 Diabetes: Implications for Prediction, Prevention and Treatment Responsiveness. Curr. Diabetes Rev. 12, 30–41 (2016)
2. K. Faerch, D.R. Witte, A.G. Tabak, L. Perreault, C. Herder, E.J. Brunner, M. Kivimaki, D. Vistisen, Trajectories of cardiometabolic risk factors before diagnosis of three subtypes of type 2 diabetes: a post-hoc analysis of the longitudinal Whitehall II cohort study. Lancet Diabetes Endocrinol 1, 43–51 (2013)
3. M.A. Abdul-Ghani, V. Lyssenko, T. Tuomi, R.A. Defronzo, L. Groop, The shape of plasma glucose concentration curve during OGTT predicts future risk of type 2 diabetes. Diabetes Metab. Res. Rev. 26, 280–286 (2010)
4. M.A. Abdul-Ghani, K. Williams, R.A. DeFronzo, M. Stern, What is the best predictor of future type 2 diabetes? Diabetes Care 30, 1544–1548 (2007)
5. A. Alyass, P. Almgren, M. Akerlund, J. Dushoff, B. Isomaa, P. Nilsson, T. Tuomi, V. Lyssenko, L. Groop, D. Meyre, Modelling of OGTT curve identifies 1 h plasma glucose level as a strong predictor of incident type 2 diabetes: results from two prospective cohorts. Diabetologia 58, 87–97 (2015)
6. M. Bergman, A. Chetrit, J. Roth, R. Dankner, Dysglycemia and long-term mortality: observations from the Israel study of glucose intolerance, obesity and hypertension. Diabetes Metab. Res. Rev. 31, 368–375 (2015)
7. R. Jagannathan, M.A. Sevick, H. Li, D. Fink, R. Dankner, A. Chetrit, J. Roth, M. Bergman, Elevated 1-hour plasma glucose levels are associated with dysglycemia, impaired beta-cell function, and insulin sensitivity: a pilot study from a real world health care setting. Endocrine 52, 172–175 (2016)
8. M. Kanauchi, K. Kimura, K. Kanauchi, Y. Saito, Beta-cell function and insulin sensitivity contribute to the shape of plasma glucose curve during an oral glucose tolerance test in non-diabetic individuals. Int. J. Clin. Pract. 59, 427–432 (2005)
9. K. Faerch, A. Vaag, J.J. Holst, C. Glumer, O. Pedersen, K. Borch-Johnsen, Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action. Diabetologia 51, 853–861 (2008)
10. J.M. Rijkelijkhuizen, C.J. Girman, A. Mari, M. Alssema, T. Rhodes, G. Nijpels, P.J. Kostense, P.P. Stein, E.M. Eekhoff, R.J. Heine, J.M. Dekker, Classical and model-based estimates of beta-cell function during a mixed meal vs. an OGTT in a population-based cohort. Diabetes Res. Clin. Pract. 83, 280–288 (2009)
11. T.P. Solomon, S.K. Malin, K. Karstoft, S.H. Knudsen, J.M. Haus, M.J. Laye, J.P. Kirwan, Association between cardiorespiratory fitness and the determinants of glycemic control across the entire glucose tolerance continuum. Diabetes Care. 38, 921–929 (2015)
12. L.H. Larsen, A.P. Gjesing, T.I. Sorensen, Y.H. Hamid, S.M. Echwald, S. Toubro, E. Black, A. Astrup, T. Hansen, O. Pedersen, Mutation analysis of the preproghrelin gene: no association with obesity and type 2 diabetes. Clin. Biochem. 38, 420–424 (2005)
13. A.P. Gjesing, C.T. Ekstrom, H. Eiberg, S.A. Urhammer, J.J. Holst, O. Pedersen, T. Hansen, Fasting and oral glucose-stimulated levels of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are highly familial traits. Diabetologia 55, 1338–1345 (2012)
14. T. Jorgensen, K. Borch-Johnsen, T.F. Thomsen, H. Ibsen, C. Glumer, C. Pisinger, A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. Eur. J. Cardiovasc. Prev. Rehabil. 10, 377–386 (2003)
15. L. Andersen, B. Dinesen, P.N. Jorgensen, F. Poulsen, M.E. Roder, Enzyme immunoassay for intact human insulin in serum or plasma. Clin. Chem. 39, 578–582 (1993)
16. C. Proust-Lima, V. Phillips, B. Liquet, Estimation of extended mixed models using latent classes and latent processes: The R package lcmm. https://arxiv.org/pdf/1503.00890.pdf. Accessed 24 Jan 2016
17. R.M. Conroy, K. Pyorala, A.P. Fitzgerald, S. Sans, A. Menotti, G. De Backer, D. De Bacquer, P. Ducimetiere, P. Jousilahti, U. Keil, I. Njolstad, R.G. Oganov, T. Thomsen, H. Tunstall-Pedoe, A. Tverdal, H. Wedel, P. Whincup, L. Wilhelmsen, I.M. Graham, Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur. Heart. J. 24, 987–1003 (2003)
18. M. Matsuda, R.A. DeFronzo, Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 22, 1462–1470 (1999)
19. D.I. Phillips, P.M. Clark, C.N. Hales, C. Osmond, Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabet. Med. 11, 286–292 (1994)
20. R Development Core Team. R: A language and environment for statistical computing. In. R Foundation for Statistical Computing, Vienna, Austria, (2015)
21. D. Carpenter, S. Dhar, L.M. Mitchell, B. Fu, J. Tyson, N.A.A. Shwan, F. Yang, M.G. Thomas, J.A.L. Armour, Obesity, starch digestion and amylase: association between copy number variants at human salivary (AMY1) and pancreatic (AMY2) amylase genes. Hum. Mol. Gen. 24, 3472–3480 (2015)
22. N. Guess, L. Perreault, A. Kerege, A. Strauss, B.C. Bergman, Dietary Fatty Acids Differentially Associate with Fasting Versus 2-Hour Glucose Homeostasis: Implications for The Management of Subtypes of Prediabetes. PLoS ONE 11, e0150148 (2016)
23. L.P. Lidegaard, A.L. Hansen, N.B. Johansen, D.R. Witte, S. Brage, T. Lauritzen, M.E. Jorgensen, D.L. Christensen, K. Faerch, Physical activity energy expenditure vs cardiorespiratory fitness level in impaired glucose metabolism. Diabetologia. 58, 2709–2717 (2015)
24. K. Faerch, K. Borch-Johnsen, A. Vaag, T. Jorgensen, D.R. Witte, Sex differences in glucose levels: a consequence of physiology or methodological convenience? The Inter99 study. Diabetologia 53, 858–865 (2010)
25. W. Rathmann, K. Strassburger, G. Giani, A. Doring, C. Meisinger, Differences in height explain gender differences in the response to the oral glucose tolerance test. Diabet. Med. 25, 1374–1375 (2008)
26. C.S. Marathe, C.K. Rayner, K.L. Jones, M. Horowitz, Relationships between gastric emptying, postprandial glycemia, and incretin hormones. Diabetes Care 36, 1396–1405 (2013)
27. K. Faerch, G. Pacini, J.J. Nolan, T. Hansen, A. Tura, D. Vistisen, Impact of glucose tolerance status, sex, and body size on glucose absorption patterns during OGTTs. Diabetes Care 36, 3691–3697 (2013)
28. J.J. Holst, F. Gribble, M. Horowitz, C.K. Rayner, Roles of the Gut in Glucose Homeostasis. Diabetes Care 39, 884–892 (2016)
29. M. Lind, J. Tuomilehto, M. Uusitupa, O. Nerman, J. Eriksson, P. Ilanne-Parikka, S. Keinanen-Kiukaanniemi, M. Peltonen, A. Pivodic, J. Lindstrom, The association between HbA1c, fasting glucose, 1-hour glucose and 2-hour glucose during an oral glucose tolerance test and cardiovascular disease in individuals with elevated risk for diabetes. PLoS ONE 9, e109506 (2014)
30. Glucose tolerance and cardiovascular mortality, comparison of fasting and 2-hour diagnostic criteria. Arch. Intern. Med. 161, 397–405 (2001)
31. S. Soulimane, D. Simon, W.H. Herman, C. Lange, C.M. Lee, S. Colagiuri, J.E. Shaw, P.Z. Zimmet, D. Magliano, S.R. Ferreira, Y. Dong, L. Zhang, T. Jorgensen, J. Tuomilehto, V. Mohan, D.L. Christensen, L. Kaduka, J.M. Dekker, G. Nijpels, C.D. Stehouwer, O. Lantieri, W.Y. Fujimoto, D.L. Leonetti, M.J. McNeely, K. Borch-Johnsen, E.J. Boyko, D. Vistisen, B. Balkau, HbA1c, fasting and 2 h plasma glucose in current, ex- and never-smokers: a meta-analysis. Diabetologia 57, 30–39 (2014)
32. M. Manco, S. Panunzi, D.P. Macfarlane, A. Golay, O. Melander, T. Konrad, J.R. Petrie, G. Mingrone, One-hour plasma glucose identifies insulin resistance and beta-cell dysfunction in individuals with normal glucose tolerance: cross-sectional data from the Relationship between Insulin Sensitivity and Cardiovascular Risk (RISC) study. Diabetes Care 33, 2090–2097 (2010)
33. L. Perreault, S.E. Kahn, C.A. Christophi, W.C. Knowler, R.F. Hamman, Regression from pre-diabetes to normal glucose regulation in the diabetes prevention program. Diabetes Care 32, 1583–1588 (2009)